The Living Heart Project: Dassault Systèmes Signs Agreement with FDA for 5-Year Collaborative Resear

The Living Heart Project: Dassault Systèmes Signs Agreement with FDA for 5-Year Collaborative Research
3DPrint.com (11/14/14) Anderson, Sarah

This May a group of more than 30 member organizations counting more than 100 cardiovascular specialists among their ranks, launched the Living Heart Project, with the goal of creating more realistic 3D models of the human heart. The models used by the Living Heart Project are build using Dassault Systèmes' 3DExperience modeling platform and data gathered from echocardiogram, magnetic resonance imaging, and CT scan images, as well as other cardiac research data. Scott Berkey, CEO of SIMULIA Dassault Systèmes, says the project is an example of how the 3DExperience platform, "can help improve product, nature, and life." Dassault recently expanded its involvement with the project, announcing a five-year collaborative research agreement with the U.S. Food and Drug Administration on Nov. 14 targeted at developing new cardiac devices to treat heart disease, particularly as regards the means of such devices' insertion, placement, and performance. Pacemaker leads are among the devices that will be studied under the agreement. "Through Dassault Systèmes’ 3DEXPERIENCE platform tailored to address unmet medical needs, as demonstrated here in cardiovascular, we support generation of new healthcare solutions and collaborative practices that will ultimately improve patient outcomes and increase patient accessibility," says Jean Colombel, vice president of life sciences at Dassault Systèmes. 

Recent Stories
Getting Ready for the COE 2015 Annual PLM Experience & TechniFair

President's Blog

COE Ask the Expert Webinars